GlassScriptPhysician profile
Mellyn A Johnson
NPI 1003181926
$4,050.62
in general payments reported to CMS, 2019-2025
11 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $446 · 2023: $1,345 · 2024: $1,654 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,646 · Travel and Lodging: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,646.24 |
| Travel and Lodging | $763.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $1,216.69 | 2021-2023 | Activ.A.C., Promogran Prisma, 3m Cavilon |
| Mimedx Group, INC. | $1,151.68 | 2024-2025 | |
| Convatec INC. | $380.75 | 2022-2025 | |
| Smith+Nephew, INC. | $342.08 | 2021-2025 | Collagenase Santyl, Acticoat 4" X 4", Versajet |
| Hollister Incorporated | $308.02 | 2022-2025 | New Image, Premier, Adapt Ceraring |
| Molnlycke Health Care US, LLC | $237.42 | 2023-2024 | Mepilex Border Post-Op Ag, Mepilex Border Sacrum, Mlnlyckez-Flo Fluidized Positioner |
| Solventum Corporation | $194.42 | 2024-2025 | V.A.C.Ulta, V.A.C. Veraflo, Activ.A.C. |
| Organogenesis INC. | $102.74 | 2024 | Puraply Wound Matrix |
| Medline Industries LP | $89.01 | 2024 | Medline Industries, INC., Medline |
| Coloplast Corp | $14.85 | 2024 | |
| Integra Lifesciences Corporation | $12.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mellyn Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.